Launching a new biotech product is a high-stakes milestone for a company, and oversight at this stage can cause lasting challenges. Medical information is required for every product launch, but companies that treat it as a mere box to check are missing a key strategic opportunity, one that can drive compliance, enhance customer experiences and support long-term success. Utilizing medical information early ensures teams are ready to address inquiry surges, regulatory demands and cross-functional challenges before they become roadblocks.
This webinar explores common risks biotech companies often overlook and are frequently seen across the industry. Attendees will gain actionable strategies to anticipate and close these gaps, strengthen launch readiness and protect brand reputation.
Key takeaways from this webinar:
- How to identify and avoid common pitfalls in first-time launches that limit scale and market success
- The role of medical information as a cross-functional connector across regulatory, commercial and safety teams
- Lessons from real-world launches that show how proactive medical information drives stronger outcomes
For biotech teams preparing for launch, this session provides clear strategies to build confidence, minimize risk and set the stage for lasting success. Don’t wait until launch day to discover what’s missing.
Register for this webinar to learn how medical information can improve biotech product launch success by mitigating risk and enabling scale.
Speakers
Graham Harding, Associate Director of Operations, Medical Communications, Thermo Fisher Scientific
Graham Harding is an Associate Director of Medical Communications at Thermo Fisher Scientific, with a PharmD and MBA from the University of North Carolina. With more than a decade of experience in medical information, he has supported US biopharmaceutical companies through product launches and the implementation of their Medical Information departments. He has contributed to industry discussions at conferences such as DIA in 2022, sharing his insights with a global audience. Graham’s extensive background and collaborative perspective make him a valuable resource for biopharmaceutical and biotech companies as they navigate product launches and build effective medical information functions.
Message Presenter
Dominique Van Hoesel, Associate Director of Operations, Medical Communications, Thermo Fisher Scientific
Dominique is an Associate Director at Thermo Fisher Scientific, where he oversees medical information support for pharmaceutical and biotech companies across EMEA. With a background in medicine and sports science, he brings more than eight years of experience in medical information. During this time, he has supported biotech partners on pre-approval products and product launches, spanning therapeutic areas from anti-epileptics to gene therapy. Dominique has a particular interest in projects that span multiple continents, drawing on his strong communication and project management skills. In 2024, Dominique co-presented at the PIPA conference on the successes and challenges of effective client-vendor relationships.
Message PresenterWho Should Attend?
This webinar will appeal to professionals from:
- Biopharmaceutical companies with a drug in Phase II or III, preparing for first-time or specialty therapy launches
- Medical Affairs, Regulatory or Safety professionals responsible for cross-functional launch readiness, ongoing efficiency gains, compliance and inquiry management
- Launch Strategy, Commercial or Project Leads coordinating planning across medical, regulatory and commercial teams, including global scale considerations
What You Will Learn
Attendees will learn:
- How to identify and avoid common pitfalls in first-time launches that limit scale and market success
- The role of medical information as a cross-functional connector across regulatory, commercial and safety teams
- Lessons from real-world launches that show how proactive medical information drives stronger outcome
Xtalks Partner
The PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD™ clinical research business of Thermo Fisher Scientific provides clinical development and analytical services that enhance customer innovation and productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, patient recruitment, all phases of clinical development, investigator sites, comprehensive laboratory services and peri- and post-approval. Our medical communications team delivers precise and quality-driven medical information to patients and HCPs who rely on it – accurately, completely, expertly, consistently and dependably.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account